-
Article
Somatostatin-analog effect on pancreatic fistula after radical gastrectomy: a pilot randomized controlled trial
Radical gastrectomy with D2 lymphadenectomy can trigger a high incidence of postoperative pancreatic fistula (POPF), which produces a poor clinical prognosis. We sought to evaluate the effect of somatostatin a...
-
Article
Open AccessTUBA1C: a new potential target of LncRNA EGFR-AS1 promotes gastric cancer progression
The lack of obvious symptoms of early gastric cancer (GC) as well as the absence of sensitive and specific biomarkers results in poor clinical outcomes. Tubulin is currently emerging as important regulators of...
-
Article
Open AccessCorrection to: CCDC12 promotes tumor development and invasion through the Snail pathway in colon adenocarcinoma
-
Article
Open AccessCCDC12 promotes tumor development and invasion through the Snail pathway in colon adenocarcinoma
Integrative expression Quantitative Trait Loci (eQTL) analysis found that rs8180040 was significantly associated with Coiled-coil domain containing 12 (CCDC12) in colon adenocarcinoma (COAD) patients. Immunohisto...
-
Article
One-stitch method vs. traditional method of protective loop ileostomy for rectal cancer: the impact of BMI obesity
Protective loop ileostomy is an effective diversion measure often used to reduce the risk of anastomotic leakage. The purpose of the present study was to evaluate the surgical outcomes of the one-stitch method...
-
Article
Open AccessLong noncoding RNA LBX2-AS1-modulated miR-4766-5p regulates gastric cancer development through targeting CXCL5
Long noncoding RNAs (LncRNAs) have been reported to critically regulate gastric cancer (GC). Recently, it was reported that LBX2 antisense RNA 1 (LBX2-AS1) is abnormally expressed in GC. However, the role of L...
-
Article
Open AccessRASAL1 induces to downregulate the SCD1, leading to suppression of cell proliferation in colon cancer via LXRα/SREBP1c pathway
Recent studies have confirmed that RASAL1 has an antitumor effect in many cancers, but its functional role and the molecular mechanism underlying in colon cancer has not been investigated.
-
Article
MiR-492 is functionally involved in Oxaliplatin resistance in colon cancer cells LS174T via its regulating the expression of CD147
Chemotherapy remains the core of anticancer treatment. However, despite the tremendous strides made in the development of targeted anticancer therapies, emergence of resistance to chemotherapeutic drugs is st...
